Simon J. Harrison

基本信息

浏览量：100

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 336 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

CTX130 Allogeneic CRISPR-Cas9-engineered Chimeric Antigen Receptor (CAR) T Cells in Patients with Advanced Clear Cell Renal Cell Carcinoma: Long-term Follow-Up and Translational Data from the Phase 1 COBALT-RCC Study

Sumanta Kumar Pal,Ben Tran,John B. Haanen,Michael Hurwitz,Adrian Sacher,Neeraj Agarwal,Nizar Tannir,Elizabeth Budde,Simon Harrison,Sebastian Klobuch,Sagar S. Patel,Mary-Lee Dequeant,

CANCER RESEARCH（2024）

引用0浏览0引用

Efficacy and Safety in Patients with Lenalidomide-Refractory Multiple Myeloma after 1-3 Prior Lines Who Received a Single Infusion of Ciltacabtagene Autoleucel As Study Treatment in the Phase 3 CARTITUDE-4 Trial

M. Hasib Sidiqi,Paolo Corradini,Duncan Purtill,Hermann Einsele,Binod Dhakal,Lionel Karlin,Salomon Manier,Shinsuke Iida,Sebastian Giebel,Simon J. Harrison,Brea Lipe,Abdullah Khan,

Transplantation and Cellular Therapyno. 2 (2024): S376-S376

引用0浏览0引用

Sustained Remission Following Finite Duration Bispecific Antibody Therapy in Patients with Relapsed/refractory Myeloma

Rajshekhar Chakraborty, Heloise Cheruvalath,Anannya Patwari,Aniko Szabo,Carolina Schinke,Binod Dhakal,Suzanne Lentzsch,Anita D'Souza,Ghulam Rehman Mohyuddin,Kelley Julian,Shonali Midha,Patrick Costello,

Blood cancer journalno. 1 (2024): 137-137

引用0浏览0WOSNATURE引用

Harnessing the Cytotoxic Granule Exocytosis to Augment the Efficacy of T-cell-engaging Bispecific Antibody Therapy

Mika Casey, Carol Lee, Sharon M. Hoyte, Rebecca L. Johnston, Wing Yu Kwok,Soi Cheng Law,Maher K. Gandhi,Simon J. Harrison,Kyohei Nakamura

Haematologica（2024）

引用0浏览0WOS引用

Carfilzomib, Thalidomide, and Dexamethasone Are Safe and Effective in Relapsed And/or Refractory Multiple Myeloma: Final Report of the Single-Arm, Multicenter, Phase II ALLG MM018/AMN002 Study

Slavisa Ninkovic,Simon J. Harrison,Je-Jung Lee,Nick Murphy,Jae Hoon Lee,Jane Estell,Vivien M. Chen,Noemi Horvath, Kihuyn Kim,Richard Eek,Bradley Augustson,Soo -Mee Bang,

HAEMATOLOGICAno. 7 (2024): 2229-2238

引用0浏览0WOS引用

Variation in Immunoglobulin Use and Impact on Survival in Myeloma

Khai Li Chai,Cameron Wellard, L. T. P. Thao,Naomi Aoki,Elizabeth M. Moore,Bradley M. Augustson, Akshay Bapat,Hilary Blacklock,Wee J. Chng, Rachel Cooke,Cecily J. Forsyth, Yeow-Tee Goh,

eJHaemno. 4 (2024): 690-697

引用0浏览0WOS引用

FOXO1 Enhances CAR T Cell Stemness, Metabolic Fitness and Efficacy

Jack D. Chan, Christina M. Scheffler,Isabelle Munoz,Kevin Sek,Joel N. Lee,Yu-Kuan Huang,Kah Min Yap,Nicole Y. L. Saw,Jasmine Li,Amanda X. Y. Chen,Cheok Weng Chan,Emily B. Derrick,

NATURE（2024）

引用0浏览0WOSNATURE引用

Abstract CT002: CTX130 Allogeneic CRISPR-Cas9-engineered Chimeric Antigen Receptor (CAR) T Cells in Patients with Advanced Clear Cell Renal Cell Carcinoma: Long-term Follow-Up and Translational Data from the Phase 1 COBALT-RCC Study

Sumanta Kumar Pal,Ben Tran,John B. Haanen,Michael Hurwitz,Adrian Sacher,Neeraj Agarwal,Nizar Tannir,Elizabeth Budde,Simon Harrison,Sebastian Klobuch,Sagar S. Patel,Mary-Lee Dequeant,

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

Targeting the Ribosome to Treat Multiple Myeloma

Kylee H. Maclachlan, Kezia Gitareja,Jian Kang,Andrew Cuddihy, Yuxi Cao,Nadine Hein,Carleen Cullinane,Ching-Seng Ang,Natalie Brajanovski,Richard B. Pearson,Amit Khot,Elaine Sanij,

MOLECULAR THERAPY ONCOLOGYno. 1 (2024)

引用0浏览0WOS引用

CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma

Sumanta K. Pal,Ben Tran,John B. A. G. Haanen,Michael E. Hurwitz,Adrian Sacher,Nizar M. Tannir,Lihua E. Budde,Simon J. Harrison,Sebastian Klobuch,Sagar S. Patel,Luis Meza,Mary-Lee Dequeant,

CANCER DISCOVERY（2024）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

助理教授

论文共 336 篇作者统计合作学者相似作者